- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04315129
Smart Catheter: A Novel Biosensor for Early Detection of Catheter Associated Urinary Tract Infection
Urinary Tract Infection (UTI) is the most common hospital acquired infection worldwide, and is most commonly associated with catheterisation of the bladder. Catheter associated urinary tract infection (CAUTI) causes increased hospital costs, increased length of stay and increased mortality. This burden of disease is, in part, mediated by a lack of diagnostic and monitoring modalities for CAUTI. Both traditional and novel UTI diagnostic tests are susceptible to false positives associated with bacterial colonisation, and correlate poorly with clinically meaningful symptomatic CAUTI. As such, the current standard of care is reliant on clinical monitoring, which is susceptible to diagnostic delays, over and under treatment.
Imperial College London have developed a wireless biosensor for continuous monitoring of catheter-urine biochemistry. This project aims to validate this biosensor and demonstrate it's potential for preemptive CAUTI diagnosis through continuous urinary biochemical monitoring.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This research project aims to demonstrate that continuous urinary biochemical monitoring using a Smart Catheter biosensor can provide rapid diagnosis of impending catheter associated urinary tract infection (CAUTI). The primary research question will then be: "Does the Smart Catheter device reduce the time to diagnosis of CAUTI?"
This will be accomplished through four studies: The aim of the first study will be to show the reliability and robustness of the Smart Catheter device through the question: "Is there any difference between the biochemical measurements from the Smart catheter device and a gold-standard laboratory measurement?"
The aim of the second and third studies aim to demonstrate the different biochemical profiles of infected and healthy urine by addressing the research question: "What is the difference in biochemical concentrations in healthy urine as compared to infected urine?" Study 3 will accomplish this by comparing infected human catheter-acquired urine as compared to uninfected human catheter-urine. Study 3 will monitor the changes in biochemical changes in an artifical bladder with artificial urine over time while an infection is induced.
The final study will demonstrate the reduced time to diagnosis in a clinical setting by addressing the research question: " What is the time difference in diagnosis of CAUTI from the CAUTI as compared to the current standard of clinical monitoring?"
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Greater LOndon
-
London, Greater LOndon, United Kingdom, W21Y
- St Mary's Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 18 years or older Subjects expected to undergo catheterisation as part of their clinical care. Signed informed consent is a prerequisite for inclusion in the study.
Exclusion Criteria:
- Consent to participate not given Known sensitivity to urinary catheters or electronic products Patients undergoing urologic procedures
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Single arm
A single arm will have biosensor (experimental) diagnoses compared to clinical (control, current standard of care).
All participants in this group willl have a biosensor, with the data masked to patients, providers and clinical researchers
|
A novel biosensor in-built into the catheter drainage system that monitors the chemical composition of the urine, with the intention of providing early diagnosis of developing infection
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time difference of diagnosis
Time Frame: From the time of catheterisation, until 72hours post-removal of catheters.
|
The time difference of biosensor diagnosis of catheter associated UTI as compared to clinical diagnosis (defined as the prescription time of new antimicrobials for suspected UTI)
|
From the time of catheterisation, until 72hours post-removal of catheters.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Sensitivity
Time Frame: From the time of catheterisation, until 72hours post-removal of catheters.
|
The proportion of those subjects who went on to develop CAUTI did the Smart Catheter correctly predict would have CAUTI?
|
From the time of catheterisation, until 72hours post-removal of catheters.
|
Specificity
Time Frame: From the time of catheterisation, until 72hours post-removal of catheters.
|
The proportion of those subjects who did not go on to develop CAUTI did the Smart Catheter correctly predict would not have CAUTI.
|
From the time of catheterisation, until 72hours post-removal of catheters.
|
False Positive Rate
Time Frame: From the time of catheterisation, until 72hours post-removal of catheters.
|
The proportion of those subjects who would not go on to have CAUTI did the Smart Catheter incorrectly predict would have CAUTI?
|
From the time of catheterisation, until 72hours post-removal of catheters.
|
False Negative Rate
Time Frame: From the time of catheterisation, until 72hours post-removal of catheters.
|
The proportion of those subjects who would go on to have CAUTI did the Smart Catheter incorrectly predict would not have CAUTI?
|
From the time of catheterisation, until 72hours post-removal of catheters.
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 17SM4299
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Catheter-Associated Urinary Tract Infection
-
Mayo ClinicCompletedUrinary Tract Infection | Infection Associated With CatheterUnited States
-
Joshua SwanThe Methodist Hospital Research Institute; Texas Southern UniversityCompletedCross Infection | Surgical Wound Infection | Pneumonia, Ventilator-associated | Catheter-related Infections | Infection Due to Indwelling Urinary CatheterUnited States
-
Medline IndustriesCompletedCatheter-Associated Urinary Tract InfectionUnited States
-
American University of Beirut Medical CenterWithdrawnCatheter-Associated Urinary Tract Infection, Ascorbic AcidLebanon
-
Wake Forest University Health SciencesCompletedCatheter-Associated Urinary Tract InfectionUnited States
-
The Cleveland ClinicAmerican Urogynecologic SocietyTerminatedCatheter-Associated Urinary Tract InfectionUnited States
-
Hospital do CoracaoHospital Israelita Albert Einstein; Hospital Moinhos de Vento; Hospital Sirio-Libanes and other collaboratorsActive, not recruitingVentilator Associated Pneumonia | Health Care Associated Infection | Catheter-Associated Urinary Tract Infection | Central Line-associated Bloodstream Infection (CLABSI)Brazil
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityCompletedCatheter-associated Urinary Tract InfectionChina
-
Khon Kaen UniversityCompletedCritically Ill Patients | Catheter Associated Urinary Tract InfectionThailand
-
Fudan UniversityShanghai Zhongshan Hospital; Huashan Hospital; Children's Hospital of Fudan University and other collaboratorsRecruitingQuality Improvement | Central Venous Catheter Associated Bloodstream Infection | CLABSI - Central Line Associated Bloodstream Infection | Central Venous Catheter Related Bloodstream Infection | Central Line Infection | CRBSI - Catheter Related Bloodstream Infection | Evidence-based Nursing PracticeChina
Clinical Trials on Smart Catheter Biosensor
-
Imperial College LondonThe Drummond Foundation (RAMC charity)RecruitingCompartment Syndrome of Leg | Limb IschemiaUnited Kingdom
-
Nadav GoldentalUnknownPost Traumatic Stress Disorder
-
LMU KlinikumCompletedPersistent Atrial FibrillationGermany
-
ContinUse Biometrics Ltd.CompletedHeart Rate | Respiratory RateIsrael
-
University of California, San FranciscoWithdrawn
-
ContinUse Biometrics Ltd.Completed
-
Mayo ClinicEnrolling by invitationHealthy | Autoimmune EpilepsyUnited States
-
University of British ColumbiaRoche Pharma AG; Health CanadaEnrolling by invitationCovid19 | Asymptomatic Shedding ViralCanada
-
Sciema UGSanminaCompleted
-
Mater Misericordiae University HospitalHealth Service Executive, IrelandCompletedPostoperative Complications | Surgery | Anesthesia | Adult ALLIreland